171 related articles for article (PubMed ID: 28987687)
1. Incidental liver lesions seen on Breast MRI: When is additional imaging warranted?
Knox M; Slanetz P; Phillips J; Fein Zachary V; Venkataraman S; Dialani V; Mehta T
Eur J Radiol; 2017 Oct; 95():319-324. PubMed ID: 28987687
[TBL] [Abstract][Full Text] [Related]
2. Incidental hepatic lesions detected on breast MRI: Rate of malignancy and implications for utilization.
Shah PK; Kafer IA; Grimaldi GM
Clin Imaging; 2018; 51():93-97. PubMed ID: 29452924
[TBL] [Abstract][Full Text] [Related]
3. Frequency and Outcomes of Incidental Breast Lesions Detected on Abdominal MRI Over a 7-Year Period.
Prabhu V; Chhor CM; Ego-Osuala IO; Xiao JM; Hindman NM; Rosenkrantz AB
AJR Am J Roentgenol; 2017 Jan; 208(1):107-113. PubMed ID: 27809561
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of hepatic masses: diagnostic significance of wedge-shaped areas of increased signal intensity surrounding the lesion.
Giovagnoni A; Terilli F; Ercolani P; Paci E; Piga A
AJR Am J Roentgenol; 1994 Nov; 163(5):1093-7. PubMed ID: 7976881
[TBL] [Abstract][Full Text] [Related]
5. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
6. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
[TBL] [Abstract][Full Text] [Related]
7. Hepatic adenoma: MR characteristics and correlation with pathologic findings.
Paulson EK; McClellan JS; Washington K; Spritzer CE; Meyers WC; Baker ME
AJR Am J Roentgenol; 1994 Jul; 163(1):113-6. PubMed ID: 8010195
[TBL] [Abstract][Full Text] [Related]
8. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely?
Lu DS; Saini S; Hahn PF; Goldberg M; Lee MJ; Weissleder R; Gerard B; Halpern E; Cats A
AJR Am J Roentgenol; 1994 May; 162(5):1095-100. PubMed ID: 8165989
[TBL] [Abstract][Full Text] [Related]
9. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
10. Giant hepatic regenerative nodules in Alagille syndrome.
Rapp JB; Bellah RD; Maya C; Pawel BR; Anupindi SA
Pediatr Radiol; 2017 Feb; 47(2):197-204. PubMed ID: 27796468
[TBL] [Abstract][Full Text] [Related]
11. Extramammary Findings on Breast MR Examinations: Frequency, Clinical Relevance, and Patient Outcomes.
Niell BL; Bennett D; Sharma A; Gazelle GS
Radiology; 2015 Jul; 276(1):56-64. PubMed ID: 25584711
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
13. Incidental liver lesions on baseline breast MRI: Outcomes on subsequent abdominal imaging.
Gluskin J; Eliades S; Raj A; Sevilimedu V; Do RKG
Clin Imaging; 2022 Apr; 84():130-134. PubMed ID: 35193080
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cavernous hemangioma: appearance on T2-weighted fast spin-echo MR imaging with and without fat suppression.
Soyer P; Dufresne AC; Somveille E; Scherrer A
AJR Am J Roentgenol; 1997 Feb; 168(2):461-5. PubMed ID: 9016227
[TBL] [Abstract][Full Text] [Related]
15. Frequency and significance of incidental liver lesions on MR enterography in adult patients.
Dane B; Bearison C; Kim S
Clin Imaging; 2021 Dec; 80():6-10. PubMed ID: 34217035
[TBL] [Abstract][Full Text] [Related]
16. MRI-visualized T2 hyperintense breast lesions: identifying clinical and imaging factors linked to malignant biopsy outcomes.
Bissell MB; Keshavarsi S; Fleming R; Au F; Kulkarni S; Ghai S; Freitas V
Breast Cancer Res Treat; 2024 May; 205(1):159-168. PubMed ID: 38305940
[TBL] [Abstract][Full Text] [Related]
17. Hepatic segmental atrophy and nodular elastosis: imaging features.
Garg I; Graham RP; VanBuren WM; Goenka AH; Torbenson MS; Venkatesh SK
Abdom Radiol (NY); 2017 Oct; 42(10):2447-2453. PubMed ID: 28456818
[TBL] [Abstract][Full Text] [Related]
18. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
19. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
20. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
